Antitussive Drugs Market, By Drug Class (Peripherally Acting Drugs and Centrally Acting Drugs), By Route of Administration (Inhalational and Oral), By Age Group (Geriatric, Pediatric and Adult), By End-Users (Homecare, Hospitals and Specialty Clinics), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Antitussive drugs market size was valued at USD 1,408.3 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.
Antitussive drugs are defined as heterogeneous medications commonly used in patients suffering from respiratory disorders to suppress dry cough. In addition, various symptoms caused by common allergies, colds, flu, hay fever, or other breathing disorders like bronchitis and sinusitis can be treated by antitussive drugs. These drugs act on the cough center in the brain to reduce the urge to cough in patients. They are either opioids or opiates such as dextromethorphan, pholcodine, and codeine. Moreover, one of the commonly used drugs is dextromethorphan over-the-counter antitussive drugs, and it is relatively safe.
Antitussive Drugs Market- Market Dynamics
- Rising cough cases and the geriatric population will augment the market growth
The major element boosting demand for antitussive drugs is cough, which will drive the market growth. In addition, the growing prevalence of respiratory disorders and the high rate of atmospheric pollution increase the cases of cough in individuals. The contagious nature of people\'s coughs and coughs is the most common purpose to visit primary care physicians across the world. Thus, persistent cough can harm a person\'s quality of life; the demand for antitussive drugs will witness steady growth. However, the high cost of antitussive drugs and the lack of healthcare infrastructure in developing nations are expected to hamper the market demand. Furthermore, the older population is more prone to chronic disease, which is anticipated to accelerate the market\'s growth rate. Thus, the rise in the geriatric population will be projected to drive the market forward.
Antitussive Drugs Market- Key Insights
- As per the analysis shared by our research analyst, the global antitussive drugs market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)
- The antitussive drugs industry has been witnessing steady growth due to the widespread occurrence of cough-related conditions, including respiratory infections, allergies, and chronic obstructive pulmonary disease (COPD). The demand for antitussive medications tends to spike during flu and cold seasons.
- Based on drug class form segmentation, Centrally Acting Drugs was predicted to show promising market share in the year 2022
- Some antitussive medications are combined with other active ingredients, such as decongestants or expectorants, to provide comprehensive relief from multiple cold and flu symptoms.
Antitussive Drugs Market- Segmentation Analysis:
The Global antitussive drugs market is segmented on the basis of drug class, route of administration, age group, end-users, and region.
The market is divided into two categories based on drug class: peripherally acting drugs, centrally acting drugs, and others. The centrally acting drugs segment is likely to maintain its dominance over the forecast period. It works in the brain by targeting the cough center, minimizing the urge to cough. Additionally, these medications are mostly preferred to treat persistent dry coughs that don\'t produce mucus. The factors propelling the market include advances in drug development, changes in healthcare policies, the prevalence of respiratory conditions, and consumer preferences for over-the-counter or prescription medications.
The market is divided into two categories based on the route of administration: inhalational, oral, and others. The oral segment is expected to hold the highest market share. It refers to a market assessment or analysis of a particular segment within the broader antitussive drugs market which are administered orally including tablets, lozenges, syrups, and capsules.
The market is divided into three categories based on age group: geriatric, pediatric, and adult. The geriatric segment is anticipated to witness speedy growth. The term geriatric population refers to individuals 65 and older. This population has special healthcare needs and traits that have implications for several industries, such as pharmaceuticals and healthcare.
The market is divided into three categories based on end-users: homecare, hospitals, specialty clinics, and others. The specialty clinics segment is likely to possess the largest market share. The segment focuses on selective medical specialties, including respiratory and pulmonology medicine. The clinics commonly engaged in clinical trials and research related to respiratory diseases. Additionally, this will assist in the testing and development of new antitussive drugs.
Antitussive Drugs Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Antitussive Drugs Market- Competitive Landscape:
Easy availability and rising awareness of these drugs will offer advantages for market growth. Moreover, the antitussive drugs market will boost as public and private organizations take initiatives to spread awareness. Rising infection cases of the upper respiratory tract and high disposable income will result in the expansion of the antitussive drugs business. An increase in the number of research and development activities will provide beneficial opportunities as well as rising drug launches and approvals will further propel the market\'s growth rate. For instance, in March 2021, Merck announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck’s New Drug Application (NDA) for gefapixant, the investigational, orally administered selective P2X3 receptor antagonist, non-narcotic under development for the unexplained chronic cough (UCC) or treatment of refractory chronic cough (RCC) in adults agency to discuss the next steps.
Recent Developments:
- For instance, in September 2021, Sun Pharmaceutical Industries Ltd. launched of a novel formulation in cough management - Chericof 12 (chlorpheniramine maleate 4 mg or dextromethorphan hydrobromide 30 mg) in India.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTITUSSIVE DRUGS MARKET KEY PLAYERS
- Teva Pharmaceutical Industries Ltd.
- Intas Pharmaceuticals Ltd.
- Bayer AG
- Aceto
- Sanofi
- Ipca Laboratories Ltd.
- 3M
- Hoffmann-La Roche Ltd.
- Hikma Pharmaceuticals PLC
- Unique Pharmaceuticals Limited
- Cipla Inc.
- Mylan N.V.
- Zydus Cadila
- Sanofi
- Novartis AG
- Aurobindo Pharma
GLOBAL ANTITUSSIVE DRUGS MARKET, BY DRUG CLASS
- Peripherally Acting Drugs
- Centrally Acting Drugs
- Others
GLOBAL ANTITUSSIVE DRUGS MARKET, BY ROUTE OF ADMINISTRATION
- Inhalational
- Oral
- Others
GLOBAL ANTITUSSIVE DRUGS MARKET, BY AGE GROUP
- Geriatric
- Pediatric
- Adult
GLOBAL ANTITUSSIVE DRUGS MARKET, BY END-USERS
- Homecare
- Hospitals
- Specialty Clinics
- Others
GLOBAL ANTITUSSIVE DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Antitussive Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Antitussive Drugs Market Snippet by Drug Class
2.1.2. Antitussive Drugs Market Snippet by Route of Administration
2.1.3. Antitussive Drugs Market Snippet by Age Group
2.1.4. Antitussive Drugs Market Snippet by End-Users
2.1.5. Antitussive Drugs Market Snippet by Country
2.1.6. Antitussive Drugs Market Snippet by Region
2.2. Competitive Insights
3. Antitussive Drugs Key Market Trends
3.1. Antitussive Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Antitussive Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Antitussive Drugs Market Opportunities
3.4. Antitussive Drugs Market Future Trends
4. Antitussive Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Antitussive Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Antitussive Drugs Market Landscape
6.1. Antitussive Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Antitussive Drugs Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
7.1.2. Peripherally Acting Drugs
7.1.3. Centrally Acting Drugs
7.1.4. Others
8. Antitussive Drugs Market – By Route of Administration
8.1. Overview
8.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
8.1.2. Inhalational
8.1.3. Oral
8.1.4. Others
9. Antitussive Drugs Market – By Age Group
9.1. Overview
9.1.1. Segment Share Analysis, By Age Group, 2022&2030 (%)
9.1.2. Geriatric
9.1.3. Pediatric
9.1.4. Adult
10. Antitussive Drugs Market – By End-Users
10.1. Overview
10.1.1. Segment Share Analysis, By End-Users, 2022&2030 (%)
10.1.2. Homecare
10.1.3. Hospitals
10.1.4. Specialty Clinics
10.1.5. Others
11. Antitussive Drugs Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
11.2. North America
11.2.1. Overview
11.2.2. Antitussive Drugs Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.6. North America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Antitussive Drugs Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Antitussive Drugs Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Antitussive Drugs Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Antitussive Drugs Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
12. Key Vendor Analysis- Antitussive Drugs Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Teva Pharmaceutical Industries Ltd.
12.2.2. Intas Pharmaceuticals Ltd.
12.2.3. Bayer AG
12.2.4. Aceto
12.2.5. Sanofi
12.2.6. Ipca Laboratories Ltd.
12.2.7. 3M
12.2.8. F. Hoffmann-La Roche Ltd.
12.2.9. Hikma Pharmaceuticals PLC
12.2.10. Unique Pharmaceuticals Limited
12.2.11. Cipla Inc.
12.2.12. Mylan N.V.
12.2.13. Zydus Cadila
12.2.14. Sanofi
12.2.15. Novartis AG
12.2.16. Aurobindo Pharma
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
